Cargando…

Construction of a Prognostic and Early Diagnosis Model for LUAD Based on Necroptosis Gene Signature and Exploration of Immunotherapy Potential

SIMPLE SUMMARY: Necroptosis plays an important role in the progression and metastasis of lung adenocarcinoma (LUAD) and regulates the inflammatory response and tumor microenvironment. First of all, through NRGs, we determined the LUAD early diagnosis model, which is composed of four necroptosis-rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Baizhuo, Wang, Yudong, Zhou, Xiaozhu, Zhang, Zhen, Ju, Haoyu, Diao, Xiaoqi, Wu, Jiaoqi, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600876/ https://www.ncbi.nlm.nih.gov/pubmed/36291937 http://dx.doi.org/10.3390/cancers14205153

Ejemplares similares

Novel Necroptosis-Related Gene Signature for Predicting Early Diagnosis and Prognosis and Immunotherapy of Gastric Cancer
por: Zhou, Xiaozhu, et al.
Publicado: (2022)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
por: Feng, Hai-Ming, et al.
Publicado: (2023)

Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma
por: Song, Yuqi, et al.
Publicado: (2022)

Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs
por: Diao, Xiayao, et al.
Publicado: (2022)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach
por: Yang, Lihong, et al.
Publicado: (2023)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

A necroptosis -related signature for predicting prognosis and immunotherapy in hepatocellular carcinoma
por: Fu, Xing, et al.
Publicado: (2022)

A promising prognostic signature for lung adenocarcinoma (LUAD) patients basing on 6 hypoxia-related genes
por: Luo, Jie, et al.
Publicado: (2021)

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer
por: Yu, Zuhu, et al.
Publicado: (2022)

Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma
por: Peng, Yue-ling, et al.
Publicado: (2023)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022)

Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2022)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
por: Lou, Yuqing, et al.
Publicado: (2022)

Development and validation of a prognostic risk signature for lung adenocarcinoma constructed by six ferroptosis, necroptosis, and pyroptosis-related lncRNAs
por: Peng, Lei, et al.
Publicado: (2022)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
por: Fu, Linhai, et al.
Publicado: (2020)

Identification of Prognostic Signature of Necroptosis-Related lncRNAs and Molecular Subtypes in Glioma
por: Zhang, Guanghao, et al.
Publicado: (2022)

Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma
por: Zhang, Jingyao, et al.
Publicado: (2023)

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
por: Che, Yinggang, et al.
Publicado: (2022)

RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation
por: Zhang, Lian, et al.
Publicado: (2023)

Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer
por: Xia, Yan, et al.
Publicado: (2022)

Construction and Validation of a Necroptosis-Related Signature Associated With the Immune Microenvironment in Liver Hepatocellular Carcinoma
por: Wang, Gongjun, et al.
Publicado: (2022)

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
por: Yu, Zuhu, et al.
Publicado: (2023)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling
por: Li, Chaohao, et al.
Publicado: (2023)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer
por: Ding, Cheng, et al.
Publicado: (2022)

Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD
por: Wang, Zixuan, et al.
Publicado: (2022)

Establishment and validation of individualized clinical prognostic markers for LUAD patients based on autophagy-related genes
por: Fei, Yuchang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ehi38mtftvlh1ifkjg8edgca63